Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
HIV-associated cancers and related diseases
R Yarchoan, TS Uldrick - New England Journal of Medicine, 2018 - Mass Medical Soc
AIDS-Associated Cancers Cancer is a leading cause of death in patients with AIDS. The
incidence of AIDS-defining cancers has been stable owing to highly active antiretroviral …
incidence of AIDS-defining cancers has been stable owing to highly active antiretroviral …
The role of sex and gender in Dermatology-from pathogenesis to clinical implications
F Lagacé, K D'Aguanno, C Prosty… - Journal of …, 2023 - journals.sagepub.com
Background Sex and gender have increasingly been recognized as significant risk factors
for many diseases, including dermatological conditions. Historically, sex and gender have …
for many diseases, including dermatological conditions. Historically, sex and gender have …
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial
Background Optimal treatment regimens for AIDS-associated Kaposi sarcoma, a frequent
contributor to morbidity and mortality among people with HIV, have not been systematically …
contributor to morbidity and mortality among people with HIV, have not been systematically …
A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory
R Moorad, E Kasonkanji, J Gumulira… - … journal of cancer, 2023 - Wiley Online Library
Kaposi sarcoma (KS) is the most common cancer in people living with HIV (PLWH) in many
countries where KS‐associated herpesvirus is endemic. Treatment has changed little in 20 …
countries where KS‐associated herpesvirus is endemic. Treatment has changed little in 20 …
Recent advances in HIV-associated Kaposi sarcoma
Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and
is an AIDS-defining illness. Despite a decline in incidence since the introduction of …
is an AIDS-defining illness. Despite a decline in incidence since the introduction of …
Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based …
Background Kaposi's sarcoma (KS) is a multifocal angioproliferative tumor involving blood
and lymphatic vessels, caused by Human Herpes Virus-8 (HHV-8). KS is an important AIDS …
and lymphatic vessels, caused by Human Herpes Virus-8 (HHV-8). KS is an important AIDS …
Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis
In sub-Saharan Africa, endemic Kaposi's sarcoma (EnKS) is still prevalent despite high
incidence of epidemic Kaposi's sarcoma (EpKS) resulting from the on-going HIV-1 epidemic …
incidence of epidemic Kaposi's sarcoma (EpKS) resulting from the on-going HIV-1 epidemic …
Malignancies in women with HIV infection
NT Oliver, EY Chiao - Current Opinion in HIV and AIDS, 2017 - journals.lww.com
Cancer in women with HIV continues to be a major source of morbidity and mortality
worldwide, especially in low-income countries. Screening strategies, primary prevention …
worldwide, especially in low-income countries. Screening strategies, primary prevention …
Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis
Background The most effective treatment for advanced AIDS-associated Kaposi sarcoma is
paclitaxel or pegylated liposomal doxorubicin (PLD); neither is routinely used in sub …
paclitaxel or pegylated liposomal doxorubicin (PLD); neither is routinely used in sub …
Lack of CD8+ T-cell co-localization with Kaposi's sarcoma-associated herpesvirus infected cells in Kaposi's sarcoma tumors
Despite the close association between Kaposi's sarcoma (KS) and immune dysfunction, it
remains unclear whether tumor infiltrating immune cells (TIIC), by their absence, presence …
remains unclear whether tumor infiltrating immune cells (TIIC), by their absence, presence …